155
Views
2
CrossRef citations to date
0
Altmetric
Articles

Effect of Cholecalciferol Supplementation on Treatment Response and IL-10 Level in Vitamin D Deficient Parthenium Dermatitis Patients: A Randomized Double-Blind Placebo-Controlled Trial

, MD, DNB, DMORCID Icon, , MD, DNB, DMORCID Icon, , MD, DNBORCID Icon & , MD, DMORCID Icon

References

  • Akhtar N, Satyam A, Anand V, Verma KK, Khatri R, Sharma A. 2010a. Dysregulation of T(H) type cytokines in the patients of parthenium induced contact dermatitis. Clin Chim Acta. 411(23–24):2024–2028. doi: 10.1016/j.cca.2010.08.030.
  • Akhtar N, Verma KK, Sharma A. 2010b. Study of pro- and anti-inflammatory cytokine profile in the patients with parthenium dermatitis. Contact Dermat. 63(4):203–208. doi: 10.1111/j.1600-0536.2009.01693.x.
  • Asadullah K, Sterry W, Volk HD. 2003. Interleukin-10 therapy–review of a new approach. Pharmacol Rev. 55(2):241–269. doi: 10.1124/pr.55.2.4.
  • Ashtari F, Toghianifar N, Zarkesh-Esfahani SH, Mansourian M. 2015. Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. Neuroimmunomodulation. 22(6):400–404. doi: 10.1159/000439278.
  • Bakdash G, van Capel TMM, Mason LMK, Kapsenberg ML, de Jong EC. 2014. Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells. Vaccine. 32(47):6294–6302. doi: 10.1016/j.vaccine.2014.08.075.
  • Barnes MS, Horigan G, Cashman KD, Hill TR, Forsythe LK, Lucey AJ, McSorley EM, Kiely M, Bonham MP, Magee PJ, et al. 2011. Maintenance of wintertime vitamin D status with cholecalciferol supplementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults. J Nutr. 141(3):476–481. doi: 10.3945/jn.110.131516.
  • Bhateria R, Renu S. 2015. Parthenium hysterophorus L.: harmful and beneficial aspects - a review. Nat Environ Pollut Technol. 14:463–474.
  • Bhatia R, Sharma VK, Ramam M, Sethuraman G, Yadav CP. 2015. Clinical profile and quality of life of patients with occupational contact dermatitis from New Delhi, India. Contact Dermat. 73(3):172–181. doi: 10.1111/cod.12411.
  • Camargo CA, Ganmaa D, Sidbury R, Erdenedelger K, Radnaakhand N, Khandsuren B. 2014. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol. 134(4):831–835.e1. doi: 10.1016/j.jaci.2014.08.002.
  • Cannell JJ, Grant WB, Holick MF. 2014. Vitamin D and inflammation. Dermatoendocrinol. 6(1):e983401. doi: 10.4161/19381980.2014.983401.
  • Cantorna MT, Snyder L, Lin Y-D, Yang L. 2015. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 7(4):3011–3021. doi: 10.3390/nu7043011.
  • Farsani ZS, Behmanesh M, Sahraian MA. 2015. Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients. J Neurol Sci. 350(1–2):18–23. doi: 10.1016/j.jns.2015.01.030.
  • Finlay AY, Khan GK. 1994. Dermatology life quality index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol. 19(3):210–216. doi: 10.1111/j.1365-2230.1994.tb01167.x.
  • Fuss IJ, Schlaak JF, Meyer Zum Buschenfelde KH, Strober W, Neurath MF. 1999. Azathioprine can modulate immunosuppression through an IL-10 mediated mechanism [Abstract]. J Pediatr Gastroenterol. 29(4):402–405.
  • Goswami R, Gupta N, Ray D, Singh N, Tomar N. 2008. Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D. Br J Nutr. 100(3):526–529. doi: 10.1017/S0007114508921711.
  • Harinarayan CV, Joshi SR. 2009. Vitamin D status in India-its implications and remedial measures. J Assoc Physicians India. 57:40–48.
  • Heine G, Niesner U, Chang H-D, Steinmeyer A, Zügel U, Zuberbier T, Radbruch A, Worm M. 2008. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol. 38(8):2210–2218. doi: 10.1002/eji.200838216.
  • Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P, Hoffmann K. 2014. A systematic review of vitamin D status in populations worldwide. Br J Nutr. 111(1):23–45. doi: 10.1017/S0007114513001840.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society. 2011. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 96(7):1911–1930. doi: 10.1210/jc.2011-0385.
  • Holick MF. 2011. Vitamin D: a d-lightful solution for health. J Investig Med. 59(6):872–880. doi: 10.2310/JIM.0b013e318214ea2d.
  • Holvik K, Ahmed LA, Forsmo S, Gjesdal CG, Grimnes G, Samuelsen SO, Schei B, Blomhoff R, Tell GS, Meyer HE. 2013. Low serum levels of 25-hydroxyvitamin D predict hip fracture in the elderly: a NOREPOS study. J Clin Endocrinol Metab. 98(8):3341–3350. doi: 10.1210/jc.2013-1468.
  • Jacobs ET, Kohler LN, Kunihiro AG, Jurutka PW. 2016. Vitamin D and colorectal, breast, and prostate cancers: a review of the epidemiological evidence. J Cancer. 7(3):232–240. doi: 10.7150/jca.13403.
  • James LK, Durham SR. 2008. Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy. 38(7):1074–1088. doi: 10.1111/j.1365-2222.2008.02976.x.
  • Khatri R, Mukhopadhyay K, Verma KK, Sethuraman G, Sharma A. 2011. Genetic predisposition to parthenium dermatitis in an Indian cohort due to lower-producing genotypes of interleukin-10 (-) 1082 G > A and (-) 819 C > T loci but no association with interferon-γ (+) 874 A > T locus. Br J Dermatol. 165(1):115–122. doi: 10.1111/j.1365-2133.2011.10248.x.
  • Krensky AM, Azzi JR, Hafler DA. 2018. Immunosuppressants and tolerogens. In: Brunton LL, Hilal-Dandan R, Knollman BC, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 13th ed. New York (NY): McGraw-Hill Medical. p. 637–654.
  • Lake DF, Briggs AD. 2018. Immunopharmacology. In: Katzung BG, editor. Basic and clinical pharmacology. 14th ed. New York (NY): McGraw-Hill Medical. p. 977–1002.
  • Lakshmi C, Srinivas C. 2012. Parthenium the terminator: an update. Indian Dermatol Online J. 3(2):89–100. doi: 10.4103/2229-5178.96698.
  • Lakshmi C, Srinivas CR. 2007. Parthenium: a wide angle view. Indian J Dermatol Venereol Leprol. 73:296–306. doi: 10.4103/0378-6323.35732.
  • Leshem YA, Hajar T, Hanifin JM, Simpson EL. 2015. What the eczema area and severity index score tells us about the severity of atopic dermatitis: an interpretability study. Br J Dermatol. 172(5):1353–1357. doi: 10.1111/bjd.13662.
  • Malley RC, Muller HK, Norval M, Woods GM. 2009. Vitamin D3 deficiency enhances contact hypersensitivity in male but not in female mice. Cell Immunol. 255(1–2):33–40. doi: 10.1016/j.cellimm.2008.09.004.
  • Malley RC, Muller HK, Norval M, Woods GM. 2013. Dietary vitamin D alters the response of the skin to UVB-irradiation depending on the genetic background of the mice. Photochem Photobiol Sci. 12(3):536–545. doi: 10.1039/C2PP25211B.
  • Matilainen JM, Räsänen A, Gynther P, Väisänen S. 2010. The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1alpha,25(OH)2D3 target genes. J Steroid Biochem Mol Biol. 121(1–2):142–145. doi: 10.1016/j.jsbmb.2010.03.020.
  • Patel S. 2011. Harmful and beneficial aspects of Parthenium hysterophorus: an update. 3 Biotech. 1(1):1–9. doi: 10.1007/s13205-011-0007-7.
  • Quirk SK, Rainwater E, Shure AK, Agrawal DK. 2016. Vitamin D in atopic dermatitis, chronic urticaria and allergic contact dermatitis. Expert Rev Clin Immunol. 12(8):839–847. doi: 10.1586/1744666X.2016.1171143.
  • Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. 2006. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 83(4):754–759. doi: 10.1093/ajcn/83.4.754.
  • Sharma VK, Sethuraman G, Bhat R. 2005. Evolution of clinical pattern of parthenium dermatitis: a study of 74 cases. Contact Dermat. 53(2):84–88. doi: 10.1111/j.0105-1873.2005.00652.x.
  • Sharma VK, Verma P, Maharaja K. 2013. Parthenium dermatitis. Photochem Photobiol Sci. 12(1):85–94. doi: 10.1039/C2PP25186H.
  • Sharma VK, Verma P. 2012. Parthenium dermatitis in India: past, present and future. Indian J Dermatol Venereol Leprol. 78(5):560–568. doi: 10.4103/0378-6323.100522.
  • Sharma VK. 2001. Patch testing with the European standard series and compositae extracts in patients with airborne contact dermatitis. Contact Dermat. 44(1):49–50. doi: 10.1034/j.1600-0536.2001.440107-23.x.
  • Sommer A, Fabri M. 2015. Vitamin D regulates cytokine patterns secreted by dendritic cells to promote differentiation of IL-22-producing T cells. PloS One. 10(6):e0130395. doi: 10.1371/journal.pone.0130395.
  • Yusupov E, Li-Ng M, Pollack S, Yeh JK, Mikhail M, Aloia JF. 2010. Vitamin D and Serum Cytokines in a Randomized Clinical Trial. Int J Endocrinol. 2010:1. pii: doi: 10.1155/2010/305054.
  • Zhao CY, Hao EY, Oh DD, Daniel BS, Martin LK, Su JC, Rodrigues M, Murrell DF. 2017. A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients. Br J Dermatol. 176(4):985–992. doi: 10.1111/bjd.15271.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.